InvestorsHub Logo
Followers 839
Posts 120480
Boards Moderated 18
Alias Born 09/05/2002

Re: jmkobers post# 829

Friday, 05/17/2019 3:47:12 PM

Friday, May 17, 2019 3:47:12 PM

Post# of 8446
There are already two phase-3 CD trials in progress…

Efficacy (ASPEN-1)—placebo comparator; 300 patients; single-injection; 36w observation; expected completion Sep 2020:
https://www.clinicaltrials.gov/ct2/show/NCT03608397

Open-label safety (ASPEN-OLS)—350 patients including rollovers from ASPEN-1; multiple-injection; 52w observation; expected completion Nov 2021:
https://www.clinicaltrials.gov/ct2/show/NCT03617367

See #msg-146260318 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News